Details of issuance or disposal
Issuance of new shares as restricted stock compensation, Issuance of new shares as performance share units
RS 269,800 shares / PSU 473,000 shares
The height of each bar represents the proportion of shares received by each allottee. The thin line below represents the number of existing shares to which these shares are added.
RS ¥489,552,100 / PSU ¥858,258,500
Less than 0.1% for both RS and PSU
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Restricted stock is stock awarded as compensation that cannot be sold during a specified period, with the restrictions lifted once the applicable conditions are met.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of new shares as restricted stock compensation, Issuance of new shares as performance share units |
| Number of shares to be issued or disposed of | RS 269,800 shares / PSU 473,000 shares |
| Issue price and disposal price | ¥1,814.5 per share |
| Total issue value | RS ¥489,552,100 / PSU ¥858,258,500 |
| Amount of funds to be raised | Total payment amount ¥1,347,810,600 / Estimated net proceeds Not disclosed |
| Payment date | 13 July 2026 |
| Intended allottee | Name The Company / Category 4 directors and 21 executive officers / Number of Shares RS: 119,800 shares, Name The Dai-ichi Life Insurance Company, Limited / Category 5 directors and 22 executive officers / Number of Shares RS: 100,400 shares, Name The Dai-ichi Frontier Life Insurance Co., Ltd. / Category 4 directors / Number of Shares RS: 18,000 shares; PSU: 45,200 shares, Name Dai-ichi Neo Life Insurance Co., Ltd. / Category 1 director / Number of Shares RS: 4,000 shares, Name Dai-ichi Life Insurance Company, Limited / Category 1 director / Number of Shares RS: 3,600 shares; PSU: 15,500 shares, Name Vertex Investment Solutions Co., Ltd. / Category 1 director / Number of Shares RS: 4,000 shares, Name Benefit One Inc. / Category 3 directors / Number of Shares RS: 10,500 shares; PSU: 14,400 shares, Name Dai-ichi Life Technocross Co., Ltd. / Category 1 director / Number of Shares RS: 3,600 shares, Name QOLead Inc. / Category 1 director / Number of Shares RS: 2,800 shares; PSU: 12,300 shares, Name Dai-ichi Life Bussan Co., Ltd. / Category 1 director / Number of Shares RS: 3,100 shares |
| Dilution Rate | Less than 0.1% for both RS and PSU |
| Basis for determining the amount to be paid | The closing price of the Company's common stock on the Prime Market of the Tokyo Stock Exchange on 19 June 2026, ¥1,814.5. No discount or premium. |
| Transfer restriction period | 3 years (from 13 July 2026 to 12 July 2029, or until the later of these dates or the date on which the prescribed semiannual securities report is filed) |
| Conditions for lifting transfer restrictions | For RS recipients, all transfer restrictions will be lifted upon expiry of the transfer restriction period, provided that the recipient has continuously held the position of director or executive officer of the Company or an eligible group company throughout the transfer restriction period. In the event of retirement or resignation for a legitimate reason, such as expiry of the term of office or reaching retirement age, the restrictions will be lifted at the prescribed time. For PSUs, the number of shares to be delivered will be calculated according to the degree of achievement of performance targets and other factors during the performance evaluation period, subject to continued service and the absence of serious misconduct, among other conditions. |
| Reason for acquisition without consideration | For RS, all shares will be acquired without consideration if the recipient becomes subject to an event specified in the agreement, such as being sentenced to imprisonment or a more severe penalty during the transfer restriction period, except where the sentence is suspended. All or part of the shares may be acquired without consideration if the Board of Directors deems this appropriate in cases such as a material violation of laws or regulations. Shares for which the transfer restrictions have not been lifted in connection with a corporate reorganization or similar event will also be acquired without consideration. For PSUs, the recipient will forfeit the right to receive the shares in cases such as attachment, a material violation of laws, regulations or internal rules, or engaging in competitive activities. |
| Categories and Number of Persons Covered | RS: 4 directors and 21 executive officers of the Company; 5 directors and 22 executive officers of Dai-ichi Life Insurance Company, Limited; 4 directors of Dai-ichi Frontier Life Insurance Co., Ltd.; 1 director of Dai-ichi Neo Life Insurance Co., Ltd.; 1 director of Dai-ichi Life Insurance Company, Limited; 1 director of Vertex Investment Solutions Co., Ltd.; 3 directors of Benefit One Inc.; 1 director of Dai-ichi Life Technocross Co., Ltd.; 1 director of QOLead Inc.; and 1 director of Dai-ichi Life Bussan Co., Ltd., PSU: 3 directors and 14 executive officers of the Company; 3 directors and 14 executive officers of Dai-ichi Life Insurance Company, Limited; 3 directors of Dai-ichi Frontier Life Insurance Co., Ltd.; 1 director of Dai-ichi Life Insurance Company, Limited; 1 director of Benefit One Inc.; and 1 director of QOLead Inc. |
| Total Stock-Based Compensation | RS ¥489,552,100 / PSU ¥858,258,500 |
| Stock Split Ratio | 4-for-1 stock split, effective 1 April 2025 |
Items this document does not state (13)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To increase the motivation and morale of directors and executive officers to contribute to enhancing shareholder value through the sustainable growth of corporate value, promote value sharing with shareholders, and provide incentives to achieve performance targets and improve performance over the medium to long term.